Tag: #TransplantMedicine
-
Post-Transplant Malignancy Risks, Prevention, and Management Strategies
Introduction: Post-transplant malignancy is one of the most concerning complications following Solid Organ Transplantation (SOT). The interplay between immunosuppressants, viral infections, and immune system modulation significantly contributes to cancer development in transplant recipients. As the demand for organ transplantation rises, understanding post-transplant malignancies, their risk factors, and prevention strategies becomes crucial. Visit Clinical Nephrology Journal…
-
Pure Red Cell Aplasia – Post Major ABO Incompatible Allogenic Stem Cell Transplantation: Role of Ibrutinib
Introduction: Pure Red Cell Aplasia (PRCA) is a recognized complication following major ABO-incompatible allogeneic stem cell transplantation (HSCT). Characterized by anemia, reticulocytopenia, and the absence of erythroblasts in the bone marrow, PRCA can significantly impact patient outcomes. Recent research explores Ibrutinib as a novel therapeutic option for managing PRCA post-HSCT, showing promising results in restoring…
Heighten Science Publications Inc. 